OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery
Nicola Antonio di Meo, Francesco Lasorsa, Monica Rutigliano, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 4, pp. 297-313
Closed Access | Times Cited: 65
Nicola Antonio di Meo, Francesco Lasorsa, Monica Rutigliano, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 4, pp. 297-313
Closed Access | Times Cited: 65
Showing 1-25 of 65 citing articles:
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
Francesco Lasorsa, Nicola Antonio di Meo, Monica Rutigliano, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1071-1071
Open Access | Times Cited: 72
Francesco Lasorsa, Nicola Antonio di Meo, Monica Rutigliano, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1071-1071
Open Access | Times Cited: 72
Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 12, pp. 3888-3888
Open Access | Times Cited: 69
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 12, pp. 3888-3888
Open Access | Times Cited: 69
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16515-16515
Open Access | Times Cited: 50
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16515-16515
Open Access | Times Cited: 50
Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13179-13179
Open Access | Times Cited: 37
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13179-13179
Open Access | Times Cited: 37
Transcriptomic and proteo-metabolic determinants of the grading system in clear cell renal cell carcinoma
Giuseppe Lucarelli, Francesco M. Lasorsa, Martina Milella, et al.
Urologic Oncology Seminars and Original Investigations (2025)
Open Access | Times Cited: 1
Giuseppe Lucarelli, Francesco M. Lasorsa, Martina Milella, et al.
Urologic Oncology Seminars and Original Investigations (2025)
Open Access | Times Cited: 1
The role of autophagy in prostate cancer and prostatic diseases: a new therapeutic strategy
Guilherme Lemos, Cícera Madri Alves de Souza Fernandes, Fábio Henrique Silva, et al.
Prostate Cancer and Prostatic Diseases (2024) Vol. 27, Iss. 2, pp. 230-238
Closed Access | Times Cited: 5
Guilherme Lemos, Cícera Madri Alves de Souza Fernandes, Fábio Henrique Silva, et al.
Prostate Cancer and Prostatic Diseases (2024) Vol. 27, Iss. 2, pp. 230-238
Closed Access | Times Cited: 5
Improved therapy for clear cell renal cell carcinoma: beta-hydroxybutyrate and quercetin target hypoxia-induced angiogenesis and multidrug resistance
Nima Mohammadipoor, Raika Naiebi, Seyed Amirhossein Mazhari, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 4
Nima Mohammadipoor, Raika Naiebi, Seyed Amirhossein Mazhari, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 4
Cellular senescence and metabolic reprogramming model based on bulk/single-cell RNA sequencing reveals PTGER4 as a therapeutic target for ccRCC
Lijie Zhou, Youmiao Zeng, Y F Liu, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Lijie Zhou, Youmiao Zeng, Y F Liu, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients
Lei Ren, Jinwen Liu, Qingyuan Lin, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Lei Ren, Jinwen Liu, Qingyuan Lin, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Bioinformatics analysis of mitochondrial metabolism-related genes demonstrates their importance in renal cell carcinoma
Mohsen Ahmadi, Maryam Motallebinezhad, Pegah Mousavi, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Mohsen Ahmadi, Maryam Motallebinezhad, Pegah Mousavi, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Potential prognostic and immunologic significances of ADAM8 in clear cell renal cell carcinoma
M CHU, Zhi Lei Zhang, Zhi Qiang Wang, et al.
Medicine (2025) Vol. 104, Iss. 5, pp. e41375-e41375
Open Access
M CHU, Zhi Lei Zhang, Zhi Qiang Wang, et al.
Medicine (2025) Vol. 104, Iss. 5, pp. e41375-e41375
Open Access
Metabolic signature of renal cell carcinoma tumours and its correlation with the urinary metabolome
Filipa Amaro, Márcia Carvalho, Carina Carvalho‐Maia, et al.
Metabolomics (2025) Vol. 21, Iss. 2
Closed Access
Filipa Amaro, Márcia Carvalho, Carina Carvalho‐Maia, et al.
Metabolomics (2025) Vol. 21, Iss. 2
Closed Access
Glycogen metabolism genes as a molecular signature for subtyping, prognostic prediction, and immunotherapy selection in clear cell renal cell carcinoma
Fangjing Ni, Xiangyin Tan, Jian Zhang, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Fangjing Ni, Xiangyin Tan, Jian Zhang, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Activation of RHO-GTPase gene pattern correlates with adverse clinical outcome and immune microenvironment in clear cell renal cell carcinoma
Kehang Guo, Pengyue Ma, Qi Yang, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Kehang Guo, Pengyue Ma, Qi Yang, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Profiling of Biofluid Metabolites with a Kinetically Differentiated Binary Biosensing Platform
Bing Qi, Ziyun Miao, Jiahui Tan, et al.
Analytical Chemistry (2025)
Closed Access
Bing Qi, Ziyun Miao, Jiahui Tan, et al.
Analytical Chemistry (2025)
Closed Access
GAMT facilitates tumor progression via inhibiting p53 in clear cell renal cell carcinoma
Bin Zheng, Kan Liu, J. Feng, et al.
Biology Direct (2025) Vol. 20, Iss. 1
Open Access
Bin Zheng, Kan Liu, J. Feng, et al.
Biology Direct (2025) Vol. 20, Iss. 1
Open Access
A pilot metabolomics study on clear cell renal cell carcinoma
Ying Gan, Z. Li, Mingjian Ruan, et al.
BMC Urology (2025) Vol. 25, Iss. 1
Open Access
Ying Gan, Z. Li, Mingjian Ruan, et al.
BMC Urology (2025) Vol. 25, Iss. 1
Open Access
LPCAT3 regulates the immune infiltration and prognosis of ccRCC patients by mediating ferroptosis and endoplasmic reticulum stress
Bei Feng, Haiying Guo, Ning Yu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Bei Feng, Haiying Guo, Ning Yu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Disulfidptosis, a novel regulated cell death to predict survival and therapeutic response in kidney renal clear cell carcinoma
Wen-Jia Chen, Jiaxin Shen, Hui Lin, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Wen-Jia Chen, Jiaxin Shen, Hui Lin, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Circulating bile acid profiles characteristics and the potential predictive role in clear cell renal cell carcinoma progression
Qichao Wang, Jingyi Cao, Guangyue Wang, et al.
BMC Nephrology (2025) Vol. 26, Iss. 1
Open Access
Qichao Wang, Jingyi Cao, Guangyue Wang, et al.
BMC Nephrology (2025) Vol. 26, Iss. 1
Open Access
MIER2/PGC1A elicits sunitinib resistance via lipid metabolism in renal cell carcinoma
Zhihao Wei, Yuzhong Ye, Chenchen Liu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 3
Zhihao Wei, Yuzhong Ye, Chenchen Liu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 3
CD276 enhances sunitinib resistance in clear cell renal cell carcinoma by promoting DNA damage repair and activation of FAK-MAPK signaling pathway
Zhiyu Zhang, Jian‐Hao Xu, Jianglei Zhang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Zhiyu Zhang, Jian‐Hao Xu, Jianglei Zhang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Diagnostic, predictive and prognostic molecular biomarkers in clear cell renal cell carcinoma: A retrospective study
Jian Deng, ShengYuan Tu, Lin Li, et al.
Cancer Reports (2024) Vol. 7, Iss. 6
Open Access | Times Cited: 3
Jian Deng, ShengYuan Tu, Lin Li, et al.
Cancer Reports (2024) Vol. 7, Iss. 6
Open Access | Times Cited: 3
HMGCS2 serves as a potential biomarker for inhibition of renal clear cell carcinoma growth
Huajie Mao, Runzhi Wang, Fengling Shao, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Huajie Mao, Runzhi Wang, Fengling Shao, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Metabolomic profiling of human bladder tissue extracts
Krzysztof Ossoliński, Tomasz Ruman, Valérie Copié, et al.
Metabolomics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Krzysztof Ossoliński, Tomasz Ruman, Valérie Copié, et al.
Metabolomics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
